Anaptysbio (ANAB) Operating Income Growth (3y) (2019 - 2026)
Anaptysbio (ANAB) Operating Income Growth (3y) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,102.16 Bn | 67,101.87 Bn | - | 16.96% |
| 2 | Nanobiotix | 1,913.50 Bn | 1,913.44 Bn | - | - |
| 3 | Akari Therapeutics | 959.56 Bn | 959.56 Bn | - | - |
| 4 | BeOne Medicines | 472.39 Bn | 467.60 Bn | 1.35 Bn | 38.78% |
| 5 | Vertex Pharmaceuticals | 122.08 Bn | 114.83 Bn | 2.59 Bn | 13.47% |
| 6 | Regeneron Pharmaceuticals | 69.98 Bn | 61.22 Bn | 3.31 Bn | -12.10% |
| 7 | Belite Bio | 62.34 Bn | 62.34 Bn | - | - |
| 8 | Argenx Se | 55.97 Bn | 50.78 Bn | 1.41 Bn | 69.02% |
| 9 | Alnylam Pharmaceuticals | 37.47 Bn | 34.46 Bn | 959.66 Mn | 55.96% |
| 10 | Anaptysbio | 1.57 Bn | 1.28 Bn | - | 7.94% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 7.94% |
| Dec 31, 2025 | 66.02% |
| Sep 30, 2025 | 46.92% |
| Jun 30, 2025 | 1.99% |
| Mar 31, 2025 | 4.63% |
| Dec 31, 2024 | 32.29% |
| Sep 30, 2024 | -49.85% |
| Jun 30, 2024 | -322.93% |
| Mar 31, 2024 | -31.97% |
| Dec 31, 2023 | -48.33% |
| Sep 30, 2023 | -15.74% |
| Jun 30, 2023 | -21.04% |
| Mar 31, 2023 | -63.00% |
| Dec 31, 2022 | -5.28% |
| Sep 30, 2022 | 4.24% |
| Jun 30, 2022 | -1.41% |
| Mar 31, 2022 | -8.62% |
| Dec 31, 2021 | -16.58% |
| Sep 30, 2021 | 26.29% |
| Jun 30, 2021 | 66.69% |